Aristotle University Of Thessaloniki (AUTH)
Ορμονικοί και ιστολογικοί προγνωστικοί δείκτες στην αντιμετώπιση ανδρικής υπογονιμότητας με εξωσωματική μικρογονιμοποίηση
Abstract
dc:descriptionInhibin B and Antimüllerian hormone (AMH) are glycoproteins produced almost exclusively by the Sertoli cells and have been proposed as direct markers of their function and indirect markers of spermatogenesis. The aims of this study were: (1) To determine serum inhibin B and AMH concentrations in a group of subfertile men with an indication for treatment with Ιntracytoplasmic Sperm Injection (ICSI) and compare this group with a control group. (2) To evaluate serum inhibin B and AMH concentrations as predictors of the recovery of sperm in testicular fine needle aspiration biopsy (FNA) in men with azoospermia. Patients and Methods: A total of 125 subfertile men were studied. The sample was consecutive and the study design cross-sectional. Inclusion criteria were: (1) subfertility defined as not achieving pregnancy after 12 months of unprotected intercourse and (2) indication for treatment with ICSI: at least two spermiograms with azoospermia or severe OAT (oligo-astheno-teratozoospermia) with a time interval of at least 70 days. Thirty-five men from the general population with no chronic disease and under no hormonal treatment, such as anabolic steroids, and nine proven fathers (conception ≤ 12 months) were used as a control group. Subfertile men underwent andrologic evaluation, including history, physical examination, at least two spermiograms with time interval of at least 70 days, hormonal profile (serum FSH, LH, PRL, total testosterone, inhibin B, AMH), imaging study (scrotum ultrasonography, colour Doppler) and cytological study (testicular FNA). Biochemical assays in seminal fluid and genetic studies were performed in subfertile men as clinically indicated. Men in the control group underwent evaluation including history, spermiogram and hormonal profile. Statistical analysis was performed with SPSS® 17.0 (SPSS Inc., USA) and MedCalc® 12.3 (MedCalc Software, Belgium). Results: Serum inhibin B concentration in subfertile men (median 47 pg/mL, range: 4–186) was significantly lower compared with control men (median 102 pg/mL, range: 34–227) (p<0.001). Similarly, serum AMH concentration in subfertile men (median 5.2 ng/mL, range: 2.0–17.5) was significantly lower compared with control men (median 11.1 ng/mL, range: 3.4–17.3) (p<0.001). There were statistically significant differences in serum inhibin B concentrations among the different groups of subfertile men, with inhibin B levels following a “progressive” pattern, with declining levels as we moved from less severe (e.g. varicocele) to more severe testicular damage (e.g. idiopathic non-obstructive azoospermia). On the other hand, there were no statistically significant differences in serum AMH concentrations among the different groups of subfertile men. Furthermore, there was a statistically significant correlation between the cytological diagnosis and inhibin B, with inhibin B levels following again a “progressive” pattern, with declining levels as we moved from less severe (e.g. mild hypospermatogenesis) to more severe cytological diagnosis (e.g. Sertoli Cell-Only Syndrome). On the contrary, there was no significant correlation between the cytological diagnosis and AMH. The comparison of the group of azoospermic men with presence of testicular spermatozoa on diagnostic FNA with the group of azoospermic men with absence of testicular spermatozoa revealed no statistically significant difference in serum inhibin B (p=0.345) and ΑΜΗ (p=1.000) concentrations between the two groups. ROC curves were constructed using testicular FNA as the reference method (presence or absence of sperm). The Area Under Curve (AUC) was 0.582 for inhibin B, 0.500 for AMH, 0.683 for FSH and 0.707 for the volume of the larger testis. In pairwise comparison of ROC curves, there was no statistically significant difference among AUCs. Therefore, none of the four parameters was superior to the others. The AUC for the ratio [volume of larger testis/FSH] was 0.735 and was significantly greater than the AUC for ΑΜΗ (p=0.04). The AUC for the ratio [inhibin B x AMH x volume of larger testis/FSH] was 0.656 and was not significantly different from the AUC of each parameter alone. In logistic regression analysis the model with FSH, inhibin B, AMH and volume of larger testis as independent variables was statistically significant (p=0.034), but only the volume of the larger testis was an independent predictor of sperm retrieval. In conclusion serum inhibin B and AMH are not superior to FSH or testicular volume as predictors of the presence of sperm in testicular FNA in men with azoospermia; they should not be used for this purpose.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Iliadou, Paschalia
- Ηλιάδου, Πασχαλία
Subjects
dc:subject × 15- Ανασταλτίνη Β
- Ανασταλτική ορμόνη των πόρων του Müller
- Ανδρική υπογονιμότητα
- Εξωσωματική μικρογονιμοποίηση
- Αναρροφητική βιοψία όρχεων με λεπτή βελόνη
- Inhibin B
- Antimullerian hormone
- Male infertility
- Intracytoplasmic sperm injection (ICSI)
- Testicular fine needle aspiration biopsy
- Testicular sperm extraction
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29389